Maszil Tablets (Clemastine Fumarate)

Adult dose

(Oral: tablets) Adults: Administer 1mg of clemastine orally in the morning and evening. Do not exceed 2mg daily. (Injection) Adults: Inject 2mg of clemastine intramuscularly or intravenously in the morning and evening. Adjust the dose as appropriate according to age and symptoms.

Child dose

(Oral: syrup) Administer the following daily doses of clemastine orally in 2 divided doses. 11-14 years: 1.3mg daily 8-10 years: 1.0mg daily 5-7 years: 0.7mg daily 3-4 years: 0.5mg daily 1-2 years: 0.4mg daily

This medication should not be used by breastfeeding women, infants under 1 year of age, or individuals allergic to this medication or other antihistamines. Patients with asthma or respiratory disease, as well as those taking MAO inhibitors, should not take this medication. Individuals with benign prostatic hyperplasia or lower urinary tract obstruction should be cautious, as the anticholinergic effects of this drug may worsen urinary difficulties. Patients with glaucoma should avoid this medication due to the risk of increased intraocular pressure. This medication contains lactose, making it unsuitable for individuals with lactose intolerance or specific metabolic disorders. Patients with stricturing peptic ulcers or pyloric duodenal obstruction should use this medication cautiously, as gastrointestinal motility may be inhibited, worsening symptoms. Individuals with hypertension, hyperthyroidism, cardiovascular diseases, or a history of bronchial asthma should also be careful when using this medication. Patients with epilepsy or convulsive disorders, as well as those allergic to E122 (tartrazine), should use this product with caution. This medication may cause drowsiness, so it is advisable to avoid driving or operating dangerous machinery while taking it. Combining it with alcohol or central nervous system depressants may enhance its effects, so consultation with a doctor is necessary. When taken with anticholinergics, the anticholinergic effects may be enhanced, requiring dosage adjustment. Women who are pregnant or may become pregnant should use this medication cautiously, as its safety has not been established, and only if necessary. Breastfeeding women should avoid this medication, as it may be transmitted through breast milk. Children or adolescents may exhibit central nervous system symptoms, so monitoring is required during use. Elderly patients may experience side effects such as dizziness, tremor, and hypotension more frequently, thus caution is advised. In cases of overdose, symptoms such as central nervous system abnormalities, vomiting, flushing, and dilated pupils may occur, and immediate treatment is required. When used as an injection, intra-arterial administration is prohibited, and intravenous administration should be performed slowly over 2-3 minutes.

temporary drowsiness

Drug interactions

Do not take this medication with MAO inhibitors. Consult with a doctor or pharmacist when combining with central nervous system depressants (hypnotics, sedatives, tranquilizers, etc.) and anticholinergics.

Food interactions

Caution is necessary when taking this medication with alcohol.

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Additionally, it is best to store it at room temperature between 1°C and 30°C, avoiding too hot or too cold areas.

Appearance

Pale yellow tablets

Package unit

1000 tablets/bottle